UK HealthCare logo

Practice areas

  • Endocrine Cancer Team
  • Gastrointestinal and Colorectal Cancer Team
  • Gynecologic Cancer Team
  • Head and Neck Cancer Team
  • Melanoma and Sarcoma (Skin Cancer) Team
  • Musculoskeletal Cancer Team
  • Pancreas Cancer Team
  • Radiation Medicine/Radiation Oncology

Faculty rank

Professor of Radiation Medicine

Clinic information

Clinical interests

  • Biliary Tumors
  • Brachytherapy (LDR, HDR and Interstitial)
  • Gynecologic Cancer
  • Head and Neck Cancer
  • Hepatic Tumors and SIR Spheres
  • Lung Cancer
  • Neuroendocrine Cancer
  • Pancreatic Cancer
  • Radiation Oncology
  • Thyroid Cancer



Osmania Medical College, Hyderabad, Andra Predesh, India


University of Kentucky, Lexington
Robert Parker Hospital, Sayre, Pa.
Post Graduate Institute of Medical Education and Research, Chandigarh, India

Certifications or Special training

American Board of Radiology, Radiation Oncology

Additional information


My name is Mahesh Kudrimoti; I received my medical degree from Osmania Medical College, Andhra Pradesh, India. I completed residencies at the University of Kentucky in Lexington, Robert Parker Hospital in Sayre, Pa. and Post Graduate Institute of Medical Education and Research in Chandigarh, India.

I am board certified by the American Board of Radiology in Radiation Oncology.


  1. Gal TJ, Streeter M, Burris J, Kudrimoti M, Ain KB, Valentino J. Quality of life impact of external beam radiotherapy for advanced thyroid carcinoma. Thyroid. 2013 Jan; 23(1):64-9. PMID: 22971127.
    View in: PubMed
  2. Shah PH, Kudrimoti M, Feddock J, Randall M. Adjuvant treatment for stage IIIC endometrial cancer: options and controversies. Gynecol Oncol. 2011 Sep; 122(3):675-83. PMID: 21664661.
    View in: PubMed
  3. Feddock J, Kudrimoti M, Randall M. No cookie-cutter oncology: individualized treatment approaches for women with corpus endometrial cancer. Expert Rev Anticancer Ther. 2010 Jul; 10(7):1087-100. PMID: 20645698.
    View in: PubMed
  4. Baker C, Dini SA, Kudrimoti M, Awan SB, Meigooni AS. Dosimetric evaluation of a newly designed low dose rate brachytherapy applicator for treatment of cervical cancer with extension into the lower vagina. J Appl Clin Med Phys. 2007; 8(2):37-46. PMID: 17592462.
    View in: PubMed
  5. Berk L, Berkey B, Rich T, Hrushesky W, Blask D, Gallagher M, Kudrimoti M, McGarry RC, Suh J, Mehta M. Randomized phase II trial of high-dose melatonin and radiation therapy for RPA class 2 patients with brain metastases (RTOG 0119). Int J Radiat Oncol Biol Phys. 2007 Jul 1; 68(3):852-7. PMID: 17418968.
    View in: PubMed
  6. Meigooni AS, Gnaster M, Dou K, Johnson EL, Meigooni NJ, Kudrimoti M. Dosimetric evaluation of parallel opposed spatially fractionated radiation therapy of deep-seated bulky tumors. Med Phys. 2007 Feb; 34(2):599-603. PMID: 17388177.
    View in: PubMed
  7. Kudrimoti M, Lee EY, Kang Y, Ahmed M, Mohiuddin M. Genetic markers predictive of response to induction chemoradiotherapy for locally advanced rectal cancers. J Ky Med Assoc. 2007 Jan; 105(1):18-22. PMID: 17310874.
    View in: PubMed
  8. Huhn JL, Regine WF, Valentino JP, Meigooni AS, Kudrimoti M, Mohiuddin M. Spatially fractionated GRID radiation treatment of advanced neck disease associated with head and neck cancer. Technol Cancer Res Treat. 2006 Dec; 5(6):607-12. PMID: 17121437.
    View in: PubMed
  9. Warren G, Grimes K, Xu Y, Kudrimoti M, St Clair W. Selectively enhanced radiation sensitivity in prostate cancer cells associated with proteasome inhibition. Oncol Rep. 2006 May; 15(5):1287-91. PMID: 16596199.
    View in: PubMed
  10. Doty JM, Gossman D, Kudrimoti M, Valentino J, Arnold S, Spring PM. Analysis of unknown primary carcinomas metastatic to the neck: diagnosis, treatment, and outcomes. J Ky Med Assoc. 2006 Feb; 104(2):57-64. PMID: 16594571.
    View in: PubMed
  11. Spring PM, Valentino J, Arnold SM, Sloan D, Kenady D, Kudrimoti M, Haydon RC, Lee C, Given C, Mohiuddin M, Regine WF. Long-term results of hyperfractionated radiation and high-dose intraarterial cisplatin for unresectable oropharyngeal carcinoma. Cancer. 2005 Oct 15; 104(8):1765-71. PMID: 16149090.
    View in: PubMed
  12. Sathishkumar S, Boyanovsky B, Karakashian AA, Rozenova K, Giltiay NV, Kudrimoti M, Mohiuddin M, Ahmed MM, Nikolova-Karakashian M. Elevated sphingomyelinase activity and ceramide concentration in serum of patients undergoing high dose spatially fractionated radiation treatment: implications for endothelial apoptosis. Cancer Biol Ther. 2005 Sep; 4(9):979-86. PMID: 16096366.
    View in: PubMed
  13. Arnold SM, Regine WF, Ahmed MM, Valentino J, Spring P, Kudrimoti M, Kenady D, Desimone P, Mohiuddin M. Low-dose fractionated radiation as a chemopotentiator of neoadjuvant paclitaxel and carboplatin for locally advanced squamous cell carcinoma of the head and neck: results of a new treatment paradigm. Int J Radiat Oncol Biol Phys. 2004 Apr 1; 58(5):1411-7. PMID: 15050317.
    View in: PubMed
  14. Siddiqua A, Chendil D, Rowland R, Meigooni AS, Kudrimoti M, Mohiuddin M, Ahmed MM. Increased expression of PSA mRNA during brachytherapy in peripheral blood of patients with prostate cancer. Urology. 2002 Aug; 60(2):270-5. PMID: 12137825.
    View in: PubMed
  15. Mohiuddin M, Kudrimoti M, Regine WF, McGrath PC, Hanna N, John W. Concurrent infusional gemcitabine and radiation in the treatment of advanced unresectable GI malignancy: a phase I study. Cancer J. 2002 May-Jun; 8(3):255-62. PMID: 12074325.
    View in: PubMed
  16. Sathishkumar S, Dey S, Meigooni AS, Regine WF, Kudrimoti MS, Ahmed MM, Mohiuddin M. The impact of TNF-alpha induction on therapeutic efficacy following high dose spatially fractionated (GRID) radiation. Technol Cancer Res Treat. 2002 Apr; 1(2):141-7. PMID: 12622521.
    View in: PubMed